Marsh & McLennan Companies (NYSE:MRSH) Given New $212.00 Price Target at JPMorgan Chase & Co.

Key Points

• JPMorgan raised its price target on Marsh & McLennan Companies from $206 to $212 and kept an overweight rating, implying about 16.7% upside from the current share price.
• Other analysts were mixed: recent updates included higher targets from Mizuho, Keefe Bruyette & Woods, and Cantor Fitzgerald, while Bank of America cut its target and maintained an underperform rating. Overall, MarketBeat shows a Hold consensus with a $200.81 average target.
• The stock rose 1.9% to $181.72, while the company reported Q1 earnings of $3.29 per share, beating estimates and posting 7.6% revenue growth year over year.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from $206.00 to $212.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an "overweight" rating on the financial services provider's stock. JPMorgan Chase & Co.'s price objective points to a potential upside of 16.66% from the stock's current price.

Other equities analysts have also issued research reports about the company. Mizuho boosted their price objective on Marsh & McLennan Companies from $194.00 to $197.00 and gave the stock a "neutral" rating in a research note on Thursday. Keefe, Bruyette & Woods raised their target price on Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a "market perform" rating in a research note on Friday, April 17th. Citigroup upgraded Marsh & McLennan Companies from a "neutral" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, May 6th. Bank of America dropped their price objective on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an "underperform" rating for the company in a report on Tuesday, April 14th. Finally, Cantor Fitzgerald lifted their target price on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an "overweight" rating in a research note on Thursday. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $200.81.

Marsh & McLennan Companies Stock Up 1.9%

NYSE MRSH traded up $3.41 during trading hours on Monday, hitting $181.72. 351,813 shares of the company's stock traded hands, compared to its average volume of 2,940,242. The stock has a market cap of $87.79 billion, a PE ratio of 22.69, a P/E/G ratio of 2.60 and a beta of 0.61. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies has a 52-week low of $156.60 and a 52-week high of $216.32.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last issued its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion for the quarter. The business's quarterly revenue was up 7.6% on a year-over-year basis. As a group, sell-side analysts predict that Marsh & McLennan Companies will post 10.37 EPS for the current fiscal year.

Insider Buying and Selling at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company's stock.

Institutional Investors Weigh In On Marsh & McLennan Companies

A number of institutional investors have recently modified their holdings of the company. Procyon Advisors LLC raised its position in Marsh & McLennan Companies by 2.5% in the 4th quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider's stock valued at $423,000 after purchasing an additional 56 shares during the last quarter. PFG Investments LLC grew its position in Marsh & McLennan Companies by 3.3% during the 4th quarter. PFG Investments LLC now owns 1,758 shares of the financial services provider's stock worth $326,000 after purchasing an additional 56 shares during the last quarter. Lindenwold Advisors INC increased its stake in Marsh & McLennan Companies by 0.4% in the third quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider's stock valued at $3,022,000 after purchasing an additional 62 shares during the period. SeaCrest Wealth Management LLC raised its holdings in shares of Marsh & McLennan Companies by 3.9% in the fourth quarter. SeaCrest Wealth Management LLC now owns 1,673 shares of the financial services provider's stock valued at $306,000 after buying an additional 63 shares during the last quarter. Finally, EP Wealth Advisors LLC boosted its stake in shares of Marsh & McLennan Companies by 0.8% during the second quarter. EP Wealth Advisors LLC now owns 8,337 shares of the financial services provider's stock worth $1,823,000 after buying an additional 69 shares during the period. 87.99% of the stock is owned by institutional investors and hedge funds.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.